Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CHRO will rise by +1,436.06% over the next 2 Weeks and hit $20.74 by Tuesday, August 5, 2025. In that time frame, CHRO's share price is expected to range between $17.93 and $23.26.
BearishAverageBullishCHRO shares rose +7.14% in Tuesday, July 1, 2025's trading session, rising from a previous close of $1.26 to move at $1.35. The stock demonstrated notable intraday movement (see CHRO's key stats for a full breakdown), fluctuating between $1.23 and $1.48, a +20.32% trading range. While recent weeks have seen some volatility, CHRO has managed to secure a -88.46% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 14.21K shares changing hands, 748.11K fewer than the previous session. This amounted to $19.18K in total market activity.
Will CHRO Continue Its Upward Trend?
According to analyst ratings and projections for CHRO, Channel Therapeutics Corporation shares are anticipated to increase by +94.27%, potentially reaching $23.56 per share by August 5, 2025. Short-term technical indicators currently suggest a bullish sentiment for CHRO. However, the stock has recorded 16 negative trading days within the past 30 sessions. Based on the CHRO stock forecast, now is a good time to buy CHRO stock because its current trading price is -93.49% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CHRO covering social and institutional perspectives.
CHRO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CHRO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 57.62% to 58.04%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 55.62%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 58.54%, maintains a neutral outlook for the long term. Insights into CHRO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Channel Therapeutics Short-Term Forecasts
CHRO Forecast For Next 5 Days
Our algorithm anticipates Channel Therapeutics (CHRO) stock could hit $16.17 by Aug 07, 2025. This represents a +1,097.71% rise from today's price, following a +14.41% change over the past five days.
CHRO Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Channel Therapeutics Corporation (CHRO) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $14.42, which would mean a +968.15% increase from the current price of $1.35. Projections for this period range from a high of $20.31 to a low of $8.03.
CHRO Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Channel Therapeutics's price over the next three months point to a rise. CHRO stock is expected to peak at $13.81 on Oct 16, 2025 after potentially dipping to - on Oct 13, 2025. On average, CHRO is likely to trade around $6.30 in the coming 90 days.
Channel Therapeutics Stock Forecast 2025
Based on our predictive models, Channel Therapeutics (CHRO) is expected to trade between - and $13.81 throughout 2025. This would result in an average price of $6.47, potentially offering investors a +379.26% return from current levels.
Channel Therapeutics Corporation Monthly Forecast 2025–2026
July 2025
According to our latest forecast models, Channel Therapeutics Corporation (CHRO) is positioned to show a strong performance in July 2025. The price is predicted to move between $6.06 and $11.87, settling at an average of $8.79. This could translate to a +551.11% gain.
August 2025
Based on current market signals, Channel Therapeutics Corporation is projected to trend august 2025. We forecast a trading range from $2.13 to $12.30, with a likely average price of $7.06. Investors could expect a potential return of +422.96%.
September 2025
Our predictive algorithms indicate Channel Therapeutics Corporation stock may see a shift in September 2025. The expected range spans $0.59–$8.28, with an average target of $4.74. This represents a positive outlook and a possible gain of +251.11%.
October 2025
Analyzing established trends, Channel Therapeutics Corporation looks set to move in October 2025. Projections place the stock between $0.00 and $13.81, averaging around $7.09. This suggests a +425.19% gain from current levels.
November 2025
Market indicators suggest Channel Therapeutics Corporation could experience notable changes during November 2025. Prices could fluctuate within $0.00 to $13.55, with a midpoint forecast of $8.04. The stock might deliver a +495.56% gain.
December 2025
Forecasting for December 2025, models estimate that Channel Therapeutics Corporation may undergo key fluctuations. If trends hold, the stock might trade between $0.86 and $9.92, averaging $5.40. This signals a positive trajectory with potential returns around +300.00%.
January 2026
According to our latest forecast models, Channel Therapeutics Corporation (CHRO) is positioned to show a strong performance in January 2026. The price is predicted to move between $0.00 and $9.32, settling at an average of $3.38. This could translate to a +150.37% gain.
February 2026
Based on current market signals, Channel Therapeutics Corporation is projected to trend february 2026. We forecast a trading range from $0.00 to $5.27, with a likely average price of $1.47. Investors could expect a potential return of +8.89%.
March 2026
Our predictive algorithms indicate Channel Therapeutics Corporation stock may see a shift in March 2026. The expected range spans $0.00–$10.00, with an average target of $4.43. This represents a positive outlook and a possible gain of +228.15%.
April 2026
Analyzing established trends, Channel Therapeutics Corporation looks set to move in April 2026. Projections place the stock between $0.73 and $10.09, averaging around $4.91. This suggests a +263.70% gain from current levels.
May 2026
Market indicators suggest Channel Therapeutics Corporation could experience notable changes during May 2026. Prices could fluctuate within $0.00 to $6.23, with a midpoint forecast of $2.05. The stock might deliver a +51.85% gain.
June 2026
Forecasting for June 2026, models estimate that Channel Therapeutics Corporation may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $5.94, averaging $0.86. This signals a cautious trajectory with potential returns around -36.30%.
July 2026
According to our latest forecast models, Channel Therapeutics Corporation (CHRO) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.00 and $2.03, settling at an average of $0.00. This could translate to a -100.00% loss.
CHRO's history of dividends and stock splits also plays a role in long-term investor confidence.